Literature DB >> 31158457

Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.

Raju Khatri1, John K Fallon2, Rebecca J B Rementer1, Natasha T Kulick1, Craig R Lee1, Philip C Smith3.   

Abstract

INTRODUCTION: Sandwich-cultured human hepatocytes (SCHHs) are the most common in vitro hepatocyte model used for studying hepatic drug disposition and hepatotoxicity. Targeted quantification of key DME and transporter protein expression is useful for in vitro-in vivo extrapolation of drug and xenobiotic clearance and developing corresponding PBPK models. However, established methods for comprehensive quantification of drug metabolizing enzyme (DMEs) and transporter expression in SCHHs are lacking. In this study, a targeted quantitative proteomic isotope dilution nanoLC-MS/MS method developed in our laboratory was adapted to quantify a panel of phase I & II DMEs and transporter proteins in SCHHs under basal and induced conditions.
METHODS: SCHHs were treated with known inducers of DMEs (Rifampin: PXR activator, CITCO: CAR activator) and transporters (CDCA: FXR activator) or with vehicle control (DMSO) for 72 h. Membrane protein was isolated from the SCHHs using a membrane extraction kit and 30 μg membrane protein was digested with trypsin. The resulting peptides were analyzed by isotope dilution nanoLC-MS/MS to quantify the DMEs and transporters.
RESULTS: Using the method, we could quantify fourteen phase I and ten phase II DMEs, and twelve uptake/efflux transporters, under basal and induced conditions in the SCHHs. Analysis showed donor to donor variation in basal protein levels of CYP450s, UGTs and transporters, and that basal protein expression of CYP450s and UGTs was higher than that of transporters. In addition, induction of key proteins in response to rifampin, CITCO and CDCA was observed. DISCUSSION: We have successfully quantified protein abundance of multiple phase I and II DMEs and uptake and efflux transporters in SCHHs using a method previously developed in our laboratory. Our method is sufficiently sensitive to quantify inter-donor differences in protein concentrations at the basal level as well as changes in protein expression in response to endogenous and exogenous stimuli.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug metabolizing enzymes; Hepatocytes; Proteomics; Quantification; SCHH model; Targeted; Transporters

Mesh:

Substances:

Year:  2019        PMID: 31158457      PMCID: PMC6701468          DOI: 10.1016/j.vascn.2019.106590

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  35 in total

1.  Characterization of androgen-regulated expression of CYP3A5 in human prostate.

Authors:  Anne-Mari Moilanen; Jukka Hakkola; Markku H Vaarala; Saila Kauppila; Pasi Hirvikoski; Jussi T Vuoristo; Robert J Edwards; Timo K Paavonen
Journal:  Carcinogenesis       Date:  2006-11-20       Impact factor: 4.944

Review 2.  Transporters as a determinant of drug clearance and tissue distribution.

Authors:  Yoshihisa Shitara; Toshiharu Horie; Yuichi Sugiyama
Journal:  Eur J Pharm Sci       Date:  2006-02-20       Impact factor: 4.384

Review 3.  Sex-specific differences in CYP450 isoforms in humans.

Authors:  Marissa J Scandlyn; Emma C Stuart; Rhonda J Rosengren
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-04       Impact factor: 4.481

Review 4.  Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.

Authors:  Brandon Swift; Nathan D Pfeifer; Kim L R Brouwer
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

Review 5.  Gender-related differences in pharmacokinetics and their clinical significance.

Authors:  E Tanaka
Journal:  J Clin Pharm Ther       Date:  1999-10       Impact factor: 2.512

6.  Identification of a nuclear receptor for bile acids.

Authors:  M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

7.  Bile acids: natural ligands for an orphan nuclear receptor.

Authors:  D J Parks; S G Blanchard; R K Bledsoe; G Chandra; T G Consler; S A Kliewer; J B Stimmel; T M Willson; A M Zavacki; D D Moore; J M Lehmann
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 8.  Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics.

Authors:  E L LeCluyse
Journal:  Chem Biol Interact       Date:  2001-05-16       Impact factor: 5.192

9.  Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes.

Authors:  Jodi M Maglich; Derek J Parks; Linda B Moore; Jon L Collins; Bryan Goodwin; Andrew N Billin; Catherine A Stoltz; Steven A Kliewer; Millard H Lambert; Timothy M Willson; John T Moore
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

10.  Absolute quantification of human uridine-diphosphate glucuronosyl transferase (UGT) enzyme isoforms 1A1 and 1A6 by tandem LC-MS.

Authors:  John K Fallon; David E Harbourt; Saber H Maleki; Fay K Kessler; Joseph K Ritter; Philip C Smith
Journal:  Drug Metab Lett       Date:  2008-08
View more
  15 in total

1.  Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and Humans.

Authors:  Aaron S Devanathan; John K Fallon; Nicole R White; Amanda P Schauer; Brian Van Horne; Kimberly Blake; Craig Sykes; Martina Kovarova; Lourdes Adamson; Leila Remling-Mulder; Paul Luciw; J Victor Garcia; Ramesh Akkina; Jason R Pirone; Philip C Smith; Angela D M Kashuba
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Comparison of Hepatic Transporter Tissue Expression in Rodents and Interspecies Hepatic OCT1 Activity.

Authors:  Bridget L Morse; John K Fallon; Anil Kolur; Andrew T Hogan; Philip C Smith; Kathleen M Hillgren
Journal:  AAPS J       Date:  2021-04-26       Impact factor: 4.009

3.  Extracellular Vesicles as Drug Delivery System for Treatment of Neurodegenerative Disorders: Optimization of the Cell Source.

Authors:  Matthew J Haney; Yuling Zhao; John K Fallon; Wang Yue; Samuel M Li; Emily E Lentz; Dorothy Erie; Philip C Smith; Elena V Batrakova
Journal:  Adv Nanobiomed Res       Date:  2021-06-29

4.  Sinusoidal Organic Anion-Transporting Polypeptide 1B1/1B3 and Bile Canalicular Multidrug Resistance-Associated Protein 2 Play an Essential Role in the Hepatobiliary Disposition of a Synthetic Cyclic Dinucleotide (STING Agonist).

Authors:  Philip Sandoval; Bei-Ching Chuang; John K Fallon; Philip C Smith; Swapan K Chowdhury; Robert J Griffin; Cindy Q Xia; Shinji Iwasaki; Paresh P Chothe
Journal:  AAPS J       Date:  2022-09-19       Impact factor: 3.603

5.  Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.

Authors:  James J Beaudoin; Jacqueline Bezençon; Noora Sjöstedt; John K Fallon; Kim L R Brouwer
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

6.  Differential Detergent Fractionation of Membrane Protein From Small Samples of Hepatocytes and Liver Tissue for Quantitative Proteomic Analysis of Drug Metabolizing Enzymes and Transporters.

Authors:  Rani J Qasem; John K Fallon; Manisha Nautiyal; Merrie Mosedale; Philip C Smith
Journal:  J Pharm Sci       Date:  2020-10-22       Impact factor: 3.534

7.  Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes.

Authors:  Raju Khatri; John K Fallon; Craig Sykes; Natasha Kulick; Rebecca J B Rementer; Taryn A Miner; Amanda P Schauer; Angela D M Kashuba; Kim A Boggess; Kim L R Brouwer; Philip C Smith; Craig R Lee
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

8.  Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats.

Authors:  Jacqueline Bezençon; Chitra Saran; Janine Hussner; James J Beaudoin; Yueping Zhang; Hong Shen; John K Fallon; Philip C Smith; Henriette E Meyer Zu Schwabedissen; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2020-10-13       Impact factor: 3.534

9.  Pregnancy-Related Hormones Increase Nifedipine Metabolism in Human Hepatocytes by Inducing CYP3A4 Expression.

Authors:  Raju Khatri; Natasha Kulick; Rebecca J B Rementer; John K Fallon; Craig Sykes; Amanda P Schauer; Melina M Malinen; Merrie Mosedale; Paul B Watkins; Angela D M Kashuba; Kim A Boggess; Philip C Smith; Kim L R Brouwer; Craig R Lee
Journal:  J Pharm Sci       Date:  2020-09-12       Impact factor: 3.534

10.  Characterization of primary mouse hepatocyte spheroids as a model system to support investigations of drug-induced liver injury.

Authors:  Manisha Nautiyal; Rani J Qasem; John K Fallon; Kristina K Wolf; Jingli Liu; Darlene Dixon; Philip C Smith; Merrie Mosedale
Journal:  Toxicol In Vitro       Date:  2020-10-03       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.